Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Maura Francese"'
Autor:
Leonardo De Luca, Carmine Riccio, Alessandro Navazio, Serafina Valente, Manlio Cipriani, Marco Corda, Alfredo De Nardo, Giuseppina Maura Francese, Cosimo Napoletano, Emanuele Tizzani, Loris Roncon, Pasquale Caldarola, Michele Massimo Gulizia, Domenico Gabrielli, Fabrizio Oliva, Furio Colivicchi
Publikováno v:
European Heart Journal Supplements. 25:D312-D322
Patients suffering from acute coronary syndrome (ACS) present a high risk of recurrence and new adverse cardiovascular events after hospital discharge. Elevated plasma LDL-cholesterol (LDL-C) levels have been shown to be a causal factor for the devel
Autor:
Fabiana Lucà, Laura Cipolletta, Stefania Angela Di Fusco, Annamaria Iorio, Andrea Pozzi, Carmelo Massimiliano Rao, Nadia Ingianni, Manuela Benvenuto, Andrea Madeo, Damiana Fiscella, Daniela Benedetto, Giuseppina Maura Francese, Sandro Gelsomino, Massimo Zecchin, Domenico Gabrielli, Michele Massimo Gulizia
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 24, Iss , Pp - (2019)
Device interrogation and management are time consuming, representing a relevant burden for pacing centers. In several situations, patients' management requires additional follow up visits.Remote Monitoring (RM) allows an optimal recall management and
Externí odkaz:
https://doaj.org/article/8da1336fe4314e0c8cd95582b47eb139
Autor:
David, Mocini, Stefania Angela, Di Fusco, Leonardo, De Luca, Pasquale, Caldarola, Manlio, Cipriani, Marco, Corda, Andrea, Di Lenarda, Alfredo, De Nardo, Giuseppina Maura, Francese, Cosimo, Napoletano, Alessandro, Navazio, Carmine, Riccio, Loris, Roncon, Emanuele, Tizzani, Federico, Nardi, Stefano, Urbinati, Serafina, Valente, Michele Massimo, Gulizia, Domenico, Gabrielli, Fabrizio, Oliva, Furio, Colivicchi
Publikováno v:
European Heart Journal Supplements. 24:C278-C288
The appropriateness of prescribing direct oral anticoagulants [dabigatran, rivaroxaban, apixaban, and edoxaban (DOACs)] is regulated on the criteria established in Phase III trials. These criteria are reported in the summary of the product characteri
Autor:
Stefania Angela, Di Fusco, Vittoria, Rizzello, Pietro, Scicchitano, Fabiana, Lucà, Vito, Altamura, Matteo, Bianco, Leonardo, De Luca, Serafina, Valente, Carmine, Riccio, Pasquale, Caldarola, Manlio, Cipriani, Giuseppina Maura, Francese, Alessandro, Navazio, Federico, Nardi, Roberto, Ceravolo, Michele Massimo, Gulizia, Domenico, Gabrielli, Fabrizio, Oliva, Furio, Colivicchi
Publikováno v:
Giornale italiano di cardiologia (2006). 23(12)
In patients with atherosclerotic disease, the occurrence of atherothrombotic events is the main determinant of morbidity and mortality. Growing evidence suggests the involvement of the coagulation pathway in the atherosclerotic process and the benefi
Autor:
Manlio Cipriani, Giuseppina Maura Francese, Furio Colivicchi, Vincenzo Amodeo, Stefano Urbinati, Andrea Di Lenarda, Pasquale Caldarola, Michele Massimo Gulizia, Nadia Aspromonte, Massimo Imazio, Loris Roncon, Giuseppe Di Pasquale, Stefano Domenicucci, Domenico Gabrielli, Gianni Casella, Adriano Murrone, Leonardo De Luca, Serafina Valente, Fortunato Scotto di Uccio
Publikováno v:
European Heart Journal Supplements : Journal of the European Society of Cardiology
The European Society of Cardiology guidelines on non-ST-elevation acute coronary syndromes suggest different temporal strategies for the angiographic study depending on the risk profile. The scientific evidence underlying the guideline recommendation
Autor:
Stefano Urbinati, Nadia Aspromonte, Vincenzo Amodeo, Luigi Tavazzi, Michele Massimo Gulizia, Massimo Imazio, Giuseppe Di Pasquale, Pasquale Caldarola, Manlio Cipriani, Loris Roncon, Domenico Gabrielli, Fortunato Scotto di Uccio, Stefano Domenicucci, Adriano Murrone, Giuseppina Maura Francese, Andrea Di Lenarda, Furio Colivicchi, Serafina Valente
Publikováno v:
European Heart Journal Supplements : Journal of the European Society of Cardiology
The COVID-19 pandemic represents an unprecedented event that has brought deep changes in hospital facilities with reshaping of the health system organization, revealing inadequacies of current hospital and local health systems. When the COVID-19 emer
Autor:
Leonardo De Luca, Andrea Rubboli, Maddalena Lettino, Marco Tubaro, Sergio Leonardi, Gianni Casella, Serafina Valente, Roberta Rossini, Alessandro Sciahbasi, Enrico Natale, Paolo Trambaiolo, Alessandro Navazio, Manlio Cipriani, Marco Corda, Alfredo De Nardo, Giuseppina Maura Francese, Cosimo Napoletano, Emanuele Tizzani, Federico Nardi, Loris Roncon, Pasquale Caldarola, Carmine Riccio, Domenico Gabrielli, Fabrizio Oliva, Michele Massimo Gulizia, Furio Colivicchi
Publikováno v:
European heart journal supplements : journal of the European Society of Cardiology. 24
Patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) with or without acute coronary syndromes (ACS) represent a subgroup with a challenging pharmacological management. Indeed, if on the one hand, antithrombotic t
Autor:
Fabio Monica, Andrea Di Lenarda, Giuseppe Milazzo, Michele Massimo Gulizia, Vincenzo De Francesco, Domenico Gabrielli, Maurizio Giuseppe Abrignani, Furio Colivicchi, Roberta Rossini, Luigi Gatta, Massimo Imazio, Marco Soncini, Fortunato Scotto di Uccio, Elisabetta Riccio, Leonardo De Luca, Maura Francese, Angelo Zullo
Publikováno v:
European Journal of Internal Medicine. 85:1-13
Aspirin and P2Y12 receptor antagonists are widely used across the spectrum of cardiovascular and cerebrovascular diseases. Gastrointestinal complications, including ulcer and bleeding, are relatively common during antiplatelet treatment and, therefor
Autor:
Stefania Angela Di Fusco, Edoardo Gronda, Edoardo Mocini, Fabiana Lucà, Irma Bisceglia, Leonardo De Luca, Pasquale Caldarola, Manlio Cipriani, Marco Corda, Alfredo De Nardo, Giuseppina Maura Francese, Cosimo Napoletano, Alessandro Navazio, Carmine Riccio, Loris Roncon, Emanuele Tizzani, Federico Nardi, Stefano Urbinati, Serafina Valente, Michele Massimo Gulizia, Domenico Gabrielli, Fabrizio Oliva, Giuseppe Imperoli, Furio Colivicchi
Publikováno v:
European heart journal supplements : journal of the European Society of Cardiology. 24
Sodium-glucose cotransporter 2 (SGLT2) inhibitors, dapagliflozin, and empagliflozin, first developed as glucose-lowering agents for the treatment of Type 2 diabetes, have been demonstrated to improve prognosis in patients with heart failure and reduc
Autor:
Federico Nardi, Paolo Giuseppe Pino, Leonardo De Luca, Carmine Riccio, Manlio Cipriani, Marco Corda, Giuseppina Maura Francese, Domenico Gabrielli, Fabrizio Oliva, Michele Massimo Gulizia, Furio Colivicchi
Publikováno v:
European heart journal supplements : journal of the European Society of Cardiology. 24
This document addresses the evaluation of the Appropriate Use Criteria (AUC) of multimodality imaging in the diagnosis and management of aortic valve disease. The goal of this AUC document is to provide a comprehensive resource for multimodality imag